Pharmacokinetic study on echinocandins for patients with septic shock following secondary peritonitis

Phase 1

• Conditions: septic shock following secondary peritonitis; MedDRA version: 19.0Level: LLTClassification code 10040580Term: Shock septicSystem Organ Class: 100000004862; MedDRA version: 19.0Level: LLTClassification code 10061135Term: Spontaneous bacterial peritonitisSystem Organ Class: 100000004862; Therapeutic area: Not possible to specify

• Registration Number: EUCTR2016-002708-17-FR
• Lead Sponsor: CHU de NIMES

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-12-14
• Last Update Posted: 15 October 2018

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 24
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified